Reduction of Glucocorticoid Receptor Function in Chronic Fatigue Syndrome
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Glucocorticoid receptor (GR) function may have aetiopathogenic significance in chronic fatigue syndrome (CFS), via its essential role in mediating inflammatory responses as well as in hypothalamic-pituitary-adrenal axis regulation. GR function can be estimated ex vivo by measuring dexamethasone (dex) modulation of cytokine response to lipopolysaccharide (LPS), and in vivo using the impact of dex on cortisol levels. This study aimed to compare the GR function between CFS (n=48), primary Sjögren’s syndrome (a disease group control) (n=27), and sedentary healthy controls (HCs) (n=20), and to investigate its relationship with clinical measures. In the GR ex vivo response assay, whole blood was diluted and incubated with LPS (to stimulate cytokine production), with or without 10 or 100 nanomolar concentrations of dex. Cytometric bead array (CBA) and flow cytometry enabled quantification of cytokine levels (TNF α, interleukin- (IL-) 6, and IL-10) in the supernatants. In the in vivo response assay, five plasma samples were taken for determination of total cortisol concentration using ELISA at half-hourly intervals on two consecutive mornings separated by ingestion of 0.5 mg of dex at 11 pm. The association of the data from the in vivo and ex vivo analyses with reported childhood adversity was also examined. CFS patients had reduced LPS-induced IL-6 and TNF α production compared to both control groups and reduced suppression of TNF α by the higher dose of dex compared to HCs. Cortisol levels, before or after dex, did not differ between CFS and HCs. Cortisol levels were more variable in CFS than HCs. In the combined group (CFS plus HC), cortisol concentrations positively and ex vivo GR function (determined by dex-mediated suppression of IL-10) negatively correlated with childhood adversity score. The results do not support the hypothesis that GR dysregulation is aetiopathogenic in CFS and suggest that current and future endocrine cross-sectional studies in CFS may be vulnerable to the confounding influence of childhood trauma which is likely increased by comorbid depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TNF-α seems to be sensitive to suppression by DEX, at least in patients with chronic fatigue syndrome (Lynn et al. 2018).”
From Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity (2021) · cites this paper as Lynn et al. 2018
In the citing paper
“Possible confounding factors [e.g., chronic fatigue syndrome (Tomas et al. 2013), childhood trauma (Lynn et al. 2018)] could have influenced our results”
From Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity (2021) · cites this paper as Lynn et al. 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009 · cited 1×
“The functionality of the glucocorticoid receptor (GR), determined by its sensitivity, affinity, and density and by its interaction with transcription factors [18], is arguably the defining factor in HPA axis regulation [19] and responsible, in a large part, for basal concentrations of cortisol throughout the day.”
BackgroundBayesian estimation supersedes the t-test
Kruschke, J. K. (2013) · Journal of Experimental Psychology: General · doi:10.1037/a0029146 · Cited by 1,530 · cited 1×
“Vague priors were used for the mean and standard deviation, and analysis was carried out using the BEST package in the R statistical environment [55].”
MethodRaison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 1×
“The heterogeneity in cortisol concentrations may suggest clinical heterogeneity within the diagnostic grouping of CFS and emphasizes the impact of disparate and competing factors on GR function including current and previous stressors, the common use of antidepressants [20, 54] (even in those who have never met criter…”
BackgroundActive Inference, homeostatic regulation and adaptive behavioural control
Pezzulo, G., Rigoli, F., & Friston, K. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.001 · Cited by 650 · cited 1×
“The aetiopathogenic relevance of this variability is unknown but it suggests a lack of precision in cortisol regulation [56].”
BackgroundA systematic review describing the prognosis of chronic fatigue syndrome.
Cairns, R., & Hotopf, M. (2005) · Occupational Medicine · doi:10.1093/occmed/kqi013 · Cited by 395 · cited 1×
“Full recovery is rare [2, 6] and comorbidity with depression is common.”
BackgroundThe Neuroendocrinology of Chronic Fatigue Syndrome
Cleare, A. J. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0014 · Cited by 315
Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome
Papadopoulos, A. S., & Cleare, A. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.153 · Cited by 280
Salivary cortisol response to awakening in chronic fatigue syndrome
Roberts, A. D. L., Wessely, S., Chalder, T., Papadopoulos, A., & Cleare, A. J. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.2.136 · Cited by 265
Tak, L. M., Cleare, A. J., Ormel, J., Manoharan, A., Kok, I. C., Wessely, S., & Rosmalen, J. G. M. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.02.002 · Cited by 230 · cited 1×
“Cross-sectional studies in CFS tend to show basal hypocortisolaemia [22, 23], attenuated diurnal variation [4, 24], an attenuated response to activation by CRH or ACTH [16, 23, 25–28], an enhanced suppression by dex [10, 17, 28–30], and an enhanced dexinduced suppression of IL-6, TNFα, IL-10, and IL-4 synthesis [21, 3…”
Background
Research works printed but not linked: 49
- 10.1093/qjmed/hcm057 · DOI · Paper page
- 10.1016/j.autrev.2008.08.003 · DOI · Paper page
- 10.7326/0003-4819-121-12-199412150-00009 · DOI · Paper page
- 10.1176/appi.ajp.160.2.221 · DOI · Paper page
- 10.1093/infdis/170.1.1 · DOI
- 2001, Psychological Medicine, 31, 1331, 10.1017/S0033291701004664 · DOI · Paper page
- 1990, Journal of Clinical Microbiology, 28, 1403, 10.1128/JCM.28.6.1403-1410.1990 · DOI · Paper page
- 10.1155/2013/784520 · DOI · Paper page
- 10.7150/ijms.12399 · DOI
- 10.1016/j.mehy.2008.11.044 · DOI
- 10.1097/00006842-199905000-00009 · DOI · Paper page
- 10.2310/6650.2001.34047 · DOI · Paper page
- 10.1034/j.1601-5215.2003.00033.x · DOI
- 10.1210/jcem-73-6-1224 · DOI · Paper page
- 10.1210/jc.2007-1747 · DOI · Paper page
- 10.1111/j.1600-0447.1998.tb10030.x · DOI · Paper page
- 10.1017/S0033291707001444 · DOI · Paper page
- 10.1097/00006842-200203000-00015 · DOI · Paper page
- 10.1016/j.psyneuen.2006.12.005 · DOI
- 10.1016/S0165-5728(01)00400-3 · DOI · Paper page
- 10.1086/517373 · DOI · Paper page
- 10.1097/PSY.0000000000000224 · DOI · Paper page
- 10.2217/14622416.7.3.475 · DOI
- 10.1111/j.1601-183X.2006.00244.x · DOI
- 10.1016/j.jad.2008.05.001 · DOI
- 10.1046/j.1365-2265.1998.00418.x · DOI · Paper page
- 10.1016/j.psyneuen.2004.06.008 · DOI
- 10.1111/j.1751-9861.2008.00033.x · DOI · Paper page
- 10.1001/archgenpsychiatry.2008.508 · doi:10.1001/archgenpsychiatry.2008.508 · Paper page
- 10.1196/annals.1366.014 · DOI · Paper page
- 10.1093/qjmed/93.6.323 · DOI · Paper page
- 10.1016/0091-3057(95)02127-2 · DOI
- 10.1023/A:1020558917955 · DOI
- 10.1016/S0022-3956(96)00063-5 · DOI · Paper page
- 1995, Structured Clinical Interview for DSM-IV Axis I disorders-Patient Edition
- 10.1136/ard.61.6.554 · DOI · Paper page
- 10.1093/rheumatology/keq240 · doi:10.1093/rheumatology/keq240
- 10.1093/occmed/kqp180 · DOI
- 10.1016/S0145-2134(02)00541-0 · DOI · Paper page
- 10.1093/clinids/18.Supplement_1.S79 · DOI · Paper page
- 10.1016/S0306-4530(02)00108-7 · DOI · Paper page
- 10.1016/j.euroneuro.2010.02.006 · DOI · Paper page
- 10.1111/j.1749-6632.2000.tb05453.x · DOI
- 2007, Neuropsychiatric Disease and Treatment, 3, 647
- 10.1038/nn1276 · DOI · Paper page
- 10.1038/nn.2270 · DOI · Paper page
- 10.1038/nature07455 · DOI · Paper page
- 10.1080/21641846.2018.1384095 · DOI
- 10.1186/s12920-017-0248-3 · DOI
Cited by
Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity
von Zimmermann, C., Böhm, L., Richter-Schmidinger, T., Kornhuber, J., Lenz, B., & Mühle, C. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-020-02288-7 · Cited by 13
Metadata
- Authors
- Lynn, M., Maclachlan, L., Finkelmeyer, A., Clark, J., Locke, J., Todryk, S., Ng, W.-F., Newton, J. L., & Watson, S.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2018-06-10
- Volume
- 2018
- Pages
- 1-11
- ISSN
- 0962-9351
- 1466-1861
- Cited by
- 13
- References
- 16
- Language
- en
- Funders
- Action for ME (MR/J002712/1)
- ME Research UK (MR/J002712/1)
- Medical Research Council (MR/J002712/1)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduction of Glucocorticoid Receptor Function in Chronic Fatigue Syndrome. https://app.cochat.ai/papers/10.1155/2018/3972104
- The paper
- Lynn, M., Maclachlan, L., Finkelmeyer, A., Clark, J., Locke, J., Todryk, S., Ng, W.-F., Newton, J. L., & Watson, S. (2018). Reduction of Glucocorticoid Receptor Function in Chronic Fatigue Syndrome. Mediators of Inflammation. https://doi.org/10.1155/2018/3972104
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.